Aadi Bioscience, Inc Email Format

Biotechnology ResearchNew Jersey, United States51-200 Employees

Aadi Bioscience, Inc. is a biotechnology company based in Morristown, New Jersey, focused on precision therapies for genetically defined cancers. It aims to advance mTOR pathway inhibition through a precision medicine approach and nanoparticle technology to address tumors driven by mTOR alterations. Its lead product has FDA approval for treating adult patients with locally advanced unresectable or metastatic malignant PEComa.

Its target market comprises oncology patients and clinicians seeking treatments for cancers defined by mTOR pathway alterations. In March 2025, Aadi Bioscience became a wholly-owned subsidiary of KAKEN Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, and the two organizations intend to continue developing products for cancers with mTOR pathway driver alterations.

Sign up for free to view info

Company overview Employee directory